Verity Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,282	Closed	-$490K	–	184
2020 Q3	$490K	Buy	4,282 +1,020	+31%	+$110K	0.37%	69
2020 Q2	$366K	Sell	3,262 -284	-8%	-$30.2K	0.34%	73
2020 Q1	$318K	Sell	3,546 -210	-6%	-$20.6K	0.4%	82
2019 Q4	$406K	Buy	3,756 +24	+0.6%	+$2.57K	0.4%	81
2019 Q3	$366K	Buy	3,732 +890	+31%	+$100K	0.38%	84
2019 Q2	$372K	Buy	2,842 +112	+4%	+$14.4K	0.42%	81
2019 Q1	$369K	Sell	2,730 -356	-12%	-$44.3K	0.43%	70
2018 Q4	$300K	Buy	3,086 +131	+4%	+$15.5K	0.4%	69
2018 Q3	$411K	Buy	2,955 +435	+17%	+$54.6K	0.41%	59
2018 Q2	$313K	Buy	+2,520	New	+$295K	0.28%	74
2018 Q1	–	Sell	-2,626	Closed	-$313K	–	150
2017 Q4	$313K	Buy	2,626 +454	+21%	+$55.3K	0.24%	77
2017 Q3	$260K	Sell	2,172 -736	-25%	-$100K	0.2%	92
2017 Q2	$354K	Buy	2,908 +482	+20%	+$56.1K	0.27%	62
2017 Q1	$294K	Buy	+2,426	New	+$313K	0.24%	76